For example, CAMKK2-AMPK signaling controls appetite and energy homeostasis in the brain [83], whereas, the CAMKK2-CAM4 axis contributes to nonalcoholic fatty liver disease (NAFLD) and is instrumental during the progression of hepatocellular carcinoma [84]. This evidence concerns the gene CAMKK2 and metabolic dysfunction-associated steatotic liver disease.